GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.

[1] In the presence of elevated glucose concentrations, GLP-1 and GIP ... beyond its proteolytic action, including T-cell activation and proliferation. Although the mechanism of action may ...

Professor Cho Young-min of the Department of Endocrine Metabolism at Seoul National University Hospital published a new book 'Super Hormone' based on more than 20 years of research and clinical ...